Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2011) 27 P39

BSPED2011 Poster Presentations (1) (84 abstracts)

Treatment strategies and outcomes of paediatric Craniopharyngioma since 2005: a single centre experience

Swathi Upadrasta , Arun Doss , Conor Mallucci , Barry Pizer , Laurence Abernethy , Urmi Das , Poonam Dharmiaj , Mohamed Didi & Jo Blair

Alder Hey Children’s NHS Foundation Trust, Liverpool, UK.

Background: The Craniopharyngioma service in our centre has changed since 2005 with a standardised preoperative assessment and a new approach to surgery and use of radiotherapy. We review the subsequent outcomes.

Treatment strategy: Preoperative endocrinology: prior to dexamethasone therapy: standard dose short synacthen test (SST), thyroid function test (TFT), IGF1, LH, FSH, testosterone/oestradiol±GH stimulation test. Staging: MRI and tumour staging (Paris classification). Cystic lesions: endoscopic decompression (ED)+repeat MRI+reclassification. Surgery: total (TR), near-total (NTR) or subtotal tumour resection (STR) determined by Paris stage. Radiotherapy: elective for residual disease in older children. Postoperative endocrinology: 5–7 days following dexamethasone: 0900 h cortisol+ACTH, low dose SST, TFT. 3–6 months: anterior pituitary function tests.

Results: Data from 23 subjects (10 M), age (median and range) 10.9 years (1.5–15.5) are reported. Treatment: ED: (n=13) seven tumours downgraded following ED. Surgery: TR 5/23, NTR 5/23, STR 11/23, awaiting surgery 2/23. Radiotherapy: 9/20 (four following tumour progression/recurrence). Auxology: baseline (n=22): height SDS, 0.89±1.55; BMI SDS, 1.46±2.53. Greater than equal to 6 months (n=18): height SDS, 0.71±1.51; BMI SDS, 1.61±1.91. Endocrinology (patients tested/patients abnormal results): i) baseline: SST 19/8, TFT 23/3, IGF1 19/10, GH 2/2, LH, FSH 15/13, diabetes insipidus (DI) 24/0. ii) Follow-up: SST 17/12, TFT 17/17, IGF1 15/10, GH 16/15, LH, FSH 17/12, DI 21/17, panhypopituitarism 17/10.

Conclusions: Pituitary hormone deficiencies are common at presentation and progress following treatment. ED led to downgrading of some tumours. This enabled more extensive resection in 50% of patients, and reduced use of radiotherapy, but short-term outcome data are comparable with previous studies.

Volume 27

39th Meeting of the British Society for Paediatric Endocrinology and Diabetes

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.